A study on relationship between androgenetic alopecia and cardiovascular risk using high sensitivity C-reactive protein and galectin-3 in men with early onset baldness

References

• Agac, M.T., et al., 2015. Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults. Journal of the European academy of dermatology and venereology: JEADV, 29(1), 26–30.
   PubMed Web of Science ®Google Scholar
• Ahouansou, S., et al. 2007. Association of androgenetic alopecia and hypertension. European journal of dermatology, 17(3), 220–222.
   Google Scholar
• Aksan, G., et al., 2016. Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis? Journal of investigative medicine, 64(3), 764–767.
   PubMed Web of Science ®Google Scholar
• Atalar, M.N., et al., 2019. Assessment of serum galectin-3, methylated arginine and Hs-CRP levels in type 2 diabetes and prediabetes. Life sciences, 231, 116577.
   PubMed Web of Science ®Google Scholar
• Cannarella, R., et al., 2020. Increased DHEAS and decreased total testosterone serum levels in a subset of men with early-onset androgenetic alopecia: does a male PCOS-equivalent exist? International journal of endocrinology, 2020, 1–8.
   Google Scholar
• Castro, A.R., Silva, S.O., and Soares, S.C., 2018. The use of high sensitivity C-reactive protein in cardiovascular disease detection. Journal of pharmacy and pharmaceutical sciences: a publication of the Canadian society for pharmaceutical sciences, societe canadienne des sciences pharmaceutiques, 21(1), 496–503.
   Google Scholar
• Cotton, S.G., et al., 1972. Factors discriminating men with coronary heart disease from healthy controls. British heart journal, 34(5), 458–464.
   PubMedGoogle Scholar
• Dušková, M., et al., 2004. What may be the markers of the male equivalent of polycystic ovary syndrome? Physiological research, 53(3), 287–295.
   PubMed Web of Science ®Google Scholar
• Ellis, J.A., Stebbing, M., and Harrap, S.B., 2001. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clinical science, 100(4), 401–404.
   Web of Science ®Google Scholar
• Ertas, R., et al., 2016. Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk. Blood pressure, 25(3), 141–148.
   PubMed Web of Science ®Google Scholar
• Goldman, B.E., Fisher, D.M., and Ringler, S.L., 1996. Transcutaneous Po2 of the scalp in male pattern baldness: a new piece to the puzzle. Plastic and reconstructive surgery, 97(6), 1109–1116.
   PubMed Web of Science ®Google Scholar
• Hara, A., et al., 2020. Galectin-3 as a next-generation biomarker for detecting early stage of various diseases. Biomolecules, 10(3), 389.
   PubMed Web of Science ®Google Scholar
• Hashimoto, J., et al., 2008. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. Journal of hypertension, 26(5), 1017–1024.
   PubMed Web of Science ®Google Scholar
• Hirsso, P., et al., 2006. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Central European journal of public health, 14 (2), 78–81.
   PubMedGoogle Scholar
• Hirsso, P., et al., 2007. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology, 214(2), 125–129.
   PubMed Web of Science ®Google Scholar
• Klemp, P., Peters, K., and Hansted, B., 1989. Subcutaneous blood flow in early male pattern baldness. Journal of investigative dermatology, 92(5), 725–726.
   PubMed Web of Science ®Google Scholar
• Laurent, S., et al., 2001. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension, 37(5), 1236–1241.
   PubMed Web of Science ®Google Scholar
• Levy-Nissenbaum, E., et al., 2005. Confirmation of the association between male pattern baldness and the androgen receptor gene. European journal of dermatology, 15(5), 339–340.
   PubMed Web of Science ®Google Scholar
• Lin, Y.H., et al., 2009. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clinica chimica acta, 409 (1-2), 96–99.
   PubMed Web of Science ®Google Scholar
• Lolli, F., et al., 2017. Androgenetic alopecia: a review. Endocrine, 57(1), 9–17.
   PubMed Web of Science ®Google Scholar
• Lotufo, P.A., et al., 2000. Male pattern baldness and coronary heart disease: the physicians’ health study. Archives of internal medicine, 160(2), 165–171.
   PubMedGoogle Scholar
• Mancia, G., et al., 2013. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Journal of hypertension, 31(10), 1925–1938.
   PubMed Web of Science ®Google Scholar
• Marie, Y., et al., 2007. Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. The American journal of pathology, 171 (3), 846–860.
   PubMed Web of Science ®Google Scholar
• Matilainen, V., Koskela, P., and Keinänen-Kiukaanniemi, S., 2000. Early androgenetic alopecia as a marker of insulin resistance. The lancet, 356(9236), 1165–1166.
   PubMed Web of Science ®Google Scholar
• Matilainen, V.A., Mäkinen, P.K., and Keinänen-Kiukaanniemi, S.M., 2001. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. Journal of cardiovascular risk, 8 (3), 147–151.
   PubMedGoogle Scholar
• Mumcuoglu, C., Ekmekci, T.R., and Ucak, S., 2011. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. European journal of dermatology, 21 (1), 79–82.
   PubMed Web of Science ®Google Scholar
• Nadrowski, P., et al., 2016. Associations between cardiovascular disease risk factors and IL-6 and hsCRP levels in the elderly. Experimental gerontology, 85, 112–117.
   PubMed Web of Science ®Google Scholar
• Narad, S., et al., 2013. Hormonal profile in Indian men with premature androgenetic alopecia. International journal of trichology, 5(2), 69–72.
   PubMedGoogle Scholar
• Norwood, O.T., 1975. Male pattern baldness: classification and incidence. Southern medical journal, 68(11), 1359–1365.
   PubMed Web of Science ®Google Scholar
• Sanke, S., et al., 2016. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA dermatology, 152(9), 986–991.
   PubMed Web of Science ®Google Scholar
• Severi, G., et al., 2003. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. British journal of dermatology, 149 (6), 1207–1213.
   PubMed Web of Science ®Google Scholar
• Sharma, K.H., and Jindal, A., 2014. Association between androgenetic alopecia and coronary artery disease in young male patients. International journal of trichology, 6(1), 5–7.
   PubMedGoogle Scholar
• Starka, L., et al., 2005. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocrine regulations, 39(4), 127–131.
   PubMedGoogle Scholar
• Su, L.H., and Chen, T.H., 2010. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey. The British journal of dermatology, 163 (2), 371–377.
   PubMed Web of Science ®Google Scholar
• Vayá, A., et al., 2015. Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia. Clinical hemorheology and microcirculation, 61(3), 471–477.
   PubMed Web of Science ®Google Scholar
• Vora, R.V., et al., 2019. Clinical profile of androgenic alopecia and its association with cardiovascular risk factors. Indian journal of dermatology, 64(1), 19–22.
   PubMed Web of Science ®Google Scholar
• Westerhof, B.E., et al., 2006. Quantification of wave reflection in the human aorta from pressure alone: a proof of principle. Hypertension (Dallas, Texas: 1979), 48(4), 595–601.
   PubMed Web of Science ®Google Scholar